ascend laboratories (uk) limited Company Information
Company Number
09164483
Next Accounts
Dec 2025
Industry
Wholesale of pharmaceutical goods
Shareholders
alkem laboratories ltd
Group Structure
View All
Contact
Registered Address
elsley court, 20-22 great titchfield street, london, W1W 8BE
Website
-ascend laboratories (uk) limited Estimated Valuation
Pomanda estimates the enterprise value of ASCEND LABORATORIES (UK) LIMITED at £2.9m based on a Turnover of £5m and 0.57x industry multiple (adjusted for size and gross margin).
ascend laboratories (uk) limited Estimated Valuation
Pomanda estimates the enterprise value of ASCEND LABORATORIES (UK) LIMITED at £301.9k based on an EBITDA of £69.7k and a 4.33x industry multiple (adjusted for size and gross margin).
ascend laboratories (uk) limited Estimated Valuation
Pomanda estimates the enterprise value of ASCEND LABORATORIES (UK) LIMITED at £1.9m based on Net Assets of £947.4k and 1.98x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ascend Laboratories (uk) Limited Overview
Ascend Laboratories (uk) Limited is a live company located in london, W1W 8BE with a Companies House number of 09164483. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in August 2014, it's largest shareholder is alkem laboratories ltd with a 100% stake. Ascend Laboratories (uk) Limited is a established, mid sized company, Pomanda has estimated its turnover at £5m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Ascend Laboratories (uk) Limited Health Check
Pomanda's financial health check has awarded Ascend Laboratories (Uk) Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 7 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
7 Weak
Size
annual sales of £5m, make it smaller than the average company (£25.9m)
- Ascend Laboratories (uk) Limited
£25.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 12%, show it is growing at a faster rate (5.7%)
- Ascend Laboratories (uk) Limited
5.7% - Industry AVG
Production
with a gross margin of 25.4%, this company has a comparable cost of product (25.4%)
- Ascend Laboratories (uk) Limited
25.4% - Industry AVG
Profitability
an operating margin of 1.4% make it less profitable than the average company (4.5%)
- Ascend Laboratories (uk) Limited
4.5% - Industry AVG
Employees
with 5 employees, this is below the industry average (39)
5 - Ascend Laboratories (uk) Limited
39 - Industry AVG
Pay Structure
on an average salary of £71.8k, the company has an equivalent pay structure (£71.8k)
- Ascend Laboratories (uk) Limited
£71.8k - Industry AVG
Efficiency
resulting in sales per employee of £1m, this is more efficient (£742.1k)
- Ascend Laboratories (uk) Limited
£742.1k - Industry AVG
Debtor Days
it gets paid by customers after 77 days, this is later than average (60 days)
- Ascend Laboratories (uk) Limited
60 days - Industry AVG
Creditor Days
its suppliers are paid after 5 days, this is quicker than average (31 days)
- Ascend Laboratories (uk) Limited
31 days - Industry AVG
Stock Days
it holds stock equivalent to 199 days, this is more than average (68 days)
- Ascend Laboratories (uk) Limited
68 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 27 weeks, this is more cash available to meet short term requirements (11 weeks)
27 weeks - Ascend Laboratories (uk) Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 87%, this is a higher level of debt than the average (51.4%)
87% - Ascend Laboratories (uk) Limited
51.4% - Industry AVG
ASCEND LABORATORIES (UK) LIMITED financials
Ascend Laboratories (Uk) Limited's latest turnover from March 2024 is estimated at £5 million and the company has net assets of £947.4 thousand. According to their latest financial statements, Ascend Laboratories (Uk) Limited has 5 employees and maintains cash reserves of £3.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 640,037 | 502,356 | 0 | |||||||
Other Income Or Grants | 0 | 0 | 0 | |||||||
Cost Of Sales | 592,033 | 386,649 | 24,607 | |||||||
Gross Profit | 48,004 | 115,707 | -24,607 | |||||||
Admin Expenses | 26,664 | 20,352 | 9,764 | |||||||
Operating Profit | 21,340 | 95,355 | -34,371 | |||||||
Interest Payable | 0 | 0 | 0 | |||||||
Interest Receivable | 0 | 0 | 0 | |||||||
Pre-Tax Profit | 21,340 | 95,355 | -34,371 | |||||||
Tax | 2,535 | -19,000 | 0 | |||||||
Profit After Tax | 23,875 | 76,355 | -34,371 | |||||||
Dividends Paid | 0 | 0 | 0 | |||||||
Retained Profit | 23,875 | 76,355 | -34,371 | |||||||
Employee Costs | ||||||||||
Number Of Employees | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 5 | 3 | |
EBITDA* | 21,340 | 95,355 | -34,371 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 1,732 | 2,157 | 1,229 | 544 | 699 | 932 | 1,243 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 1,732 | 2,157 | 1,229 | 544 | 699 | 932 | 1,243 | 0 | 0 | 0 |
Stock & work in progress | 2,046,638 | 1,341,371 | 1,232,313 | 1,419,857 | 562,537 | 990,886 | 423,272 | 176,340 | 69,309 | 0 |
Trade Debtors | 1,063,897 | 1,082,568 | 511,017 | 656,865 | 893,197 | 582,417 | 248,168 | 215,726 | 116,039 | 0 |
Group Debtors | 628,002 | 312,057 | 578,001 | 596,185 | 615,801 | 705,949 | 0 | 0 | 0 | 0 |
Misc Debtors | 165,481 | 165,680 | 158,621 | 157,214 | 288,358 | 205,774 | 458,406 | 34,067 | 7,313 | 37,421 |
Cash | 3,389,491 | 1,358,693 | 1,513,808 | 1,909,926 | 1,898,087 | 1,499,881 | 2,863,668 | 262,020 | 330,921 | 5,783 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 7,293,509 | 4,260,369 | 3,993,760 | 4,740,047 | 4,257,980 | 3,984,907 | 3,993,514 | 688,153 | 523,582 | 43,204 |
total assets | 7,295,241 | 4,262,526 | 3,994,989 | 4,740,591 | 4,258,679 | 3,985,839 | 3,994,757 | 688,153 | 523,582 | 43,204 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 53,722 | 80,230 | 34,772 | 27,073 | 18,218 | 1,435,523 | 40,722 | 105,537 | 12,848 | 21,575 |
Group/Directors Accounts | 5,828,862 | 3,093,506 | 3,132,276 | 3,959,429 | 3,519,465 | 2,176,337 | 3,602,929 | 405,239 | 340,400 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 435,266 | 286,814 | 137,793 | 121,268 | 146,785 | 37,473 | 75,695 | 11,518 | 28,350 | 6,000 |
total current liabilities | 6,317,850 | 3,460,550 | 3,304,841 | 4,107,770 | 3,684,468 | 3,649,333 | 3,719,346 | 522,294 | 381,598 | 27,575 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 30,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 30,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 6,347,850 | 3,460,550 | 3,304,841 | 4,107,770 | 3,684,468 | 3,649,333 | 3,719,346 | 522,294 | 381,598 | 27,575 |
net assets | 947,391 | 801,976 | 690,148 | 632,821 | 574,211 | 336,506 | 275,411 | 165,859 | 141,984 | 15,629 |
total shareholders funds | 947,391 | 801,976 | 690,148 | 632,821 | 574,211 | 336,506 | 275,411 | 165,859 | 141,984 | 15,629 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||
Operating Profit | 21,340 | 95,355 | -34,371 | |||||||
Depreciation | 494 | 275 | 122 | 155 | 233 | 311 | 0 | 0 | 0 | 0 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | 2,535 | -19,000 | 0 | |||||||
Stock | 705,267 | 109,058 | -187,544 | 857,320 | -428,349 | 567,614 | 246,932 | 107,031 | 69,309 | 0 |
Debtors | 297,075 | 312,666 | -162,625 | -387,092 | 303,216 | 787,566 | 456,781 | 126,441 | 85,931 | 37,421 |
Creditors | -26,508 | 45,458 | 7,699 | 8,855 | -1,417,305 | 1,394,801 | -64,815 | 92,689 | -8,727 | 21,575 |
Accruals and Deferred Income | 148,452 | 149,021 | 16,525 | -25,517 | 109,312 | -38,222 | 64,177 | -16,832 | 22,350 | 6,000 |
Deferred Taxes & Provisions | 30,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | -133,740 | -65,262 | -44,217 | |||||||
Investing Activities | ||||||||||
capital expenditure | ||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||
Financing Activities | ||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 2,735,356 | -38,770 | -827,153 | 439,964 | 1,343,128 | -1,426,592 | 3,197,690 | 64,839 | 340,400 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||
interest | 0 | 0 | 0 | |||||||
cash flow from financing | 64,839 | 390,400 | 50,000 | |||||||
cash and cash equivalents | ||||||||||
cash | 2,030,798 | -155,115 | -396,118 | 11,839 | 398,206 | -1,363,787 | 2,601,648 | -68,901 | 325,138 | 5,783 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 2,030,798 | -155,115 | -396,118 | 11,839 | 398,206 | -1,363,787 | 2,601,648 | -68,901 | 325,138 | 5,783 |
ascend laboratories (uk) limited Credit Report and Business Information
Ascend Laboratories (uk) Limited Competitor Analysis
Perform a competitor analysis for ascend laboratories (uk) limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mid companies, companies in W1W area or any other competitors across 12 key performance metrics.
ascend laboratories (uk) limited Ownership
ASCEND LABORATORIES (UK) LIMITED group structure
Ascend Laboratories (Uk) Limited has no subsidiary companies.
Ultimate parent company
ALKEM LABORATORIES LTD
#0094940
1 parent
ASCEND LABORATORIES (UK) LIMITED
09164483
ascend laboratories (uk) limited directors
Ascend Laboratories (Uk) Limited currently has 4 directors. The longest serving directors include Mr Amit Ghare (Aug 2014) and Mr Manish Narang (Aug 2014).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Amit Ghare | United Kingdom | 53 years | Aug 2014 | - | Director |
Mr Manish Narang | United Kingdom | 54 years | Aug 2014 | - | Director |
Mr Amit Kumar | England | 44 years | Sep 2016 | - | Director |
Mr Alok Verma | United Kingdom | 69 years | Feb 2017 | - | Director |
P&L
March 2024turnover
5m
+9%
operating profit
69.2k
0%
gross margin
25.5%
+8.02%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
947.4k
+0.18%
total assets
7.3m
+0.71%
cash
3.4m
+1.49%
net assets
Total assets minus all liabilities
ascend laboratories (uk) limited company details
company number
09164483
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
August 2014
age
10
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
March 2024
previous names
N/A
accountant
SRLV AUDIT LIMITED
auditor
-
address
elsley court, 20-22 great titchfield street, london, W1W 8BE
Bank
-
Legal Advisor
-
ascend laboratories (uk) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to ascend laboratories (uk) limited.
ascend laboratories (uk) limited Companies House Filings - See Documents
date | description | view/download |
---|